Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The study aimed to reduce traces of HIV in the body and help the immune system fight the virus without chronic medication.

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV infection for as long as a year. Spotlight reports on this and some of the ...

The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...

taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated, according ...

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...